Fresenius Medical Care stock at EUR 39.80 on September 25, 2026
Published on 09/28/2026 at 07:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Ahead of the next regular session, Fresenius Medical Care AG & Co. KGaA shares listed in Frankfurt last traded at EUR 39.80 on September 25, 2026, up 1.14 percent from the previous close.
Reference session
The Frankfurt-listed ordinary share uses the ticker FME. The last-traded price was recorded at 3:36:55 p.m. UTC on September 25, 2026.
China portfolio changes
In a September 25, 2026 press release, Fresenius Medical Care said it would discontinue local production and sales of the 4008A hemodialysis system and exit its China peritoneal dialysis business while maintaining existing obligations.
The company said the portfolio actions are expected to result in approximately EUR 110 million in one-time costs, primarily related to impairment charges, scrappage and termination costs. The charge is expected to be recognized as a special item in the third quarter of 2026.
Share buyback program
Fresenius Medical Care’s investor-relations page states that its 2026/2027 buyback program covers shares with ISIN DE0005785802 and has a planned total volume of approximately EUR 1 billion, excluding ancillary costs. The first tranche began on May 28, 2026, and is planned to run through December 15, 2026, according to the company’s share-buyback information.
